Viewing Study NCT00907894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-02-09 @ 3:30 PM
Study NCT ID: NCT00907894
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2009-05-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic hepatitis B, View
None telbivudine, View
None pharmacokinetics, View
None safety, View
None tolerability, View
None pediatric View